Ken Griffin Akoya Biosciences, Inc. Transaction History
Citadel Advisors LLC
- $483 Billion
- Q2 2024
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Akoya Biosciences, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 6,600 shares of AKYA stock, worth $21,384. This represents 0.0% of its overall portfolio holdings.
Number of Shares
6,600
Previous 8,000
17.5%
Holding current value
$21,384
Previous $37,000
59.46%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding AKYA
# of Institutions
61Shares Held
12MCall Options Held
67.9KPut Options Held
0-
Blue Water Life Science Advisors, LP Larkspur, CA4.7MShares$15.2 Million10.69% of portfolio
-
Black Rock Inc. New York, NY1.5MShares$4.87 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.46MShares$4.74 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA562KShares$1.82 Million0.0% of portfolio
-
State Street Corp Boston, MA435KShares$1.41 Million0.0% of portfolio
About Akoya Biosciences, Inc.
- Ticker AKYA
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 37,892,300
- Market Cap $123M
- Description
- Akoya Biosciences, Inc., a life sciences technology company, provides spatial biology solutions focused on transforming discovery and clinical research in North America, the Asia Pacific, Europe, the Middle East, and Africa. The company offers PhenoCycler instrument, a compact bench-top fluidics system that integrates with a companion microscope...